The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Entecavir
Entecavir · ENTECAVIR ANHYDROUS 1 mg/1 · Tablet · Oral · Camber Pharmaceuticals, Inc.
NDC 31722-0834-90 · 90 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for entecavir (oral solid) in the next 90 days
4 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Hetero Labs LimitedIndiamanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA205740
- TE code
- AB
- Approval date
- Aug 21, 2015
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedJul 20, 2017Hetero USA Inc — Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.
Manufacturers of Entecavir (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Health Packaging | ENTECAVIR .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | ENTECAVIR 1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | ENTECAVIR .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | ENTECAVIR ANHYDROUS 1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | ENTECAVIR ANHYDROUS .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Carlsbad Technology, Inc. | ENTECAVIR .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Epic Pharma, Llc | ENTECAVIR .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Epic Pharma, Llc | ENTECAVIR 1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | ENTECAVIR .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Entecavir — NDC 31722-0834-90," retrieved September 3, 2026, https://drugdashboards.com/drug/31722083490.
Free to cite with attribution — see how the data is put together.